Compare FIP & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIP | RGNX |
|---|---|---|
| Founded | 2021 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 568.4M | 528.6M |
| IPO Year | 2021 | 2015 |
| Metric | FIP | RGNX |
|---|---|---|
| Price | $4.64 | $10.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $11.00 | ★ $28.75 |
| AVG Volume (30 Days) | ★ 1.6M | 1.5M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | 16.91 | ★ 18.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,520,000.00 | $10,393,000.00 |
| Revenue This Year | $58.19 | $51.21 |
| Revenue Next Year | $30.58 | $19.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 51.59 | ★ 126.48 |
| 52 Week Low | $3.06 | $5.46 |
| 52 Week High | $6.69 | $16.19 |
| Indicator | FIP | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 60.20 | 50.97 |
| Support Level | $4.56 | $7.95 |
| Resistance Level | $4.66 | $11.64 |
| Average True Range (ATR) | 0.34 | 0.66 |
| MACD | 0.11 | 0.04 |
| Stochastic Oscillator | 97.23 | 64.30 |
FTAI Infrastructure Inc is engaged in five segments; Railroad segment, which includes eight freight railroads and one switching company that provide rail service to certain manufacturing and production facilities; the Jefferson Terminal segment, which consists of a multi-modal crude oil and refined products terminal and other related assets; The Repauno segment, which consists of a deep-water port located along the Delaware River with an underground storage cavern, a multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities; Power and Gas segment, which comprised Long Ridge, a multi-modal terminal located along the Ohio River; and Sustainability and Energy Transition segment, which comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.